Younger Men With Erectile Dysfunction At Double Risk Of Heart Disease
Men who experience erectile dysfunction between the ages of 40 and 49 are twice as likely to develop heart disease than men without dysfunction, according to a new Mayo Clinic study. Researchers also found that men with erectile dysfunction have an 80 percent higher risk of heart disease.
“The highest risk for coronary heart disease was in younger men,” says researcher Jennifer St. Sauver, Ph.D. The study was published in the February 2009 issue of Mayo Clinic Proceedings. The results suggest that younger men and their doctors may need to consider erectile dysfunction a harbinger of future risk of coronary heart disease — and take appropriate steps to prevent it, says Dr. St. Sauver.
Levitra Improves Erectile Function
Levitra Improves Erectile Function in Patients Taking High Blood Pressure Medications.
Levitra is one of three FDA approved oral phosphodiesterase type 5 (PDE5) inhibitors which are used to treat erectile dysfunction. The other two are Cialis and Viagra. PDE5 inhibitors relax narrowed or hardened penile arteries to the point where they will allow blood to enter the penis and create an erection in patients with ED.
Fake Cialis linked to dangerously low blood sugar
An unusual outbreak of dangerously low blood sugar has been traced to illegal anti-impotence drugs and herbal remedies contaminated with a drug for diabetics, doctors warn.
Between Jan. 1 and May 26, 2008, 150 non-diabetic patients with severe hypoglycemia were admitted to public hospital in Singapore. There were four deaths, and seven patients remained comatose, Dr. Kok Onn Lee of National University Hospital in Singapore report in Thursday’s New England Journal of Medicine.
All of the patients except one were men, and they ranged in age from 19 to 97, with an average age of 51.
Doctor defends free handouts of Viagra
A Dublin doctor has defended the millions of euro of taxpayers’ money spent making Viagra and similar products free for medical card holders.
Dr Colm Brady, a GP who specialises in impotence treatment, said the results of treatments for erectile dysfunction far outweigh the costs.
He said the tablets are generally used by over-70s and, as widespread medical card availablity becomes more restricted, the bill for these medicines will be reduced.
Pfizer’s future tied to biotechnology
The Pfizer Inc. of the future will concentrate less on blockbuster pills like Viagra and Lipitor and more on targeting unmet medical needs through biotechnology.
In an interview with the Tribune, Chairman and Chief Executive Jeffrey Kindler said Pfizer no longer wants to rely primarily on a few multibillion-dollar blockbusters. That, he said, is the key reason Pfizer last month announced its $68 billion acquisition of Wyeth, one of the first large pharmaceutical companies to invest in biotech.
Instead, the world’s largest drug company is focused on biotechnology-derived vaccines and drugs that target such diseases as cancer and Alzheimer’s, a change from its focus on routine maintenance pills for cholesterol, blood pressure and depression.
-
-
Recently Written
- Viagra and other fun with the health-care bill
- Cialis shown to help with muscle dystrophy
- Viagra aids in conceiving
- Virginia is for Viagra
- SIX MILLION MEN BUY VIAGRA ONLINE
- Viagra as a primary method of treatment of erectile dysfunction
- Generic Viagra will enable to get erection with Longer Effectiveness
- The Popularity Of Viagra Brings About A Cultural Change In Men
- Cialis Being Used To Treat Tumours
- Fake Viagra factory raided in Israel
-
Categories
